The most complex engineering of human cell lines ever has been achieved by scientists, revealing that our genomes are more ...

It’s a new way to create “bi-paternal” mice that can survive to adulthood—but human applications are still a long way off.

In the closing of the recent trading day, CRISPR Therapeutics AG (CRSP) stood at $41.21, denoting a -1.44% change from the preceding trading day. ZUG, Switzerland and BOSTON, Jan. 29, 2025 (GLOBE ...

The idea behind the notorious CRISPR-baby scandal, editing reproductive cells or ... together they increase a person’s risk of these complex diseases. Doctors already use technologies that screen ...

Get Instant Summarized Text (Gist) CRISPR nucleases, Cas9 and Cas12, have been engineered to evade immune detection, addressing a key challenge in CRISPR-based therapies. By identifying and ...

Mackie and colleagues present a valuable comparison of lateralized gustation in two well-studied nematodes. The evidence they present that ASEL/R lateralization exists and is achieved by different ...

The global Preimplantation Genetic Testing (PGT) market is on the rise, projected to reach US$ 1.65 billion by 2033, driven ...

Despite its potential, the CRISPR/Cas9 system for genome editing is accompanied by a series of limitations and challenges. These issues include off-target effects, complex genome structures, low ...